Efficacy of Tisagenlecleucel in Adult Patients (Pts) with High-Risk Relapsed/Refractory Follicular Lymphoma (r/r FL): Subgroup Analysis of the Phase II Elara Study
暂无分享,去创建一个
M. Kersten | P. Riedell | R. Malladi | P. Zinzani | M. Dreyling | J. Pérez-Simón | S. Schuster | H. Harigae | A. Ferreri | J. Chavez | C. Andreadis | M. Dickinson | F. Offner | C. Thieblemont | J. Martínez-López | E. Bachy | Koji Kato | A. Viardot | T. Teshima | C. Lobetti Bodoni | A. Petzer | L. Nastoupil | N. Fowler | A. Kolstad | B. von Tresckow | P. Patten | L. Popplewell | J. Butler | M. Ghosh | A. Chen | P. Ho | Aisha Masood | J. Mcguirk | Aiesha Zia